首頁 > 市場調查報告書 > 製藥

癌症生物製劑

市場調查報告書

商品編碼

1608866

癌症單株抗體市場：按來源、按應用、按最終用戶、按地區

Cancer Monoclonal Antibodies Market, By Source, By Application, By End User, By Geography

出版日期: 2024年11月19日 | 出版商:

Coherent Market Insights | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

癌症單株抗體市場預計到2024年將達到966.8億美元，預計到2031年將達到2,631.7億美元，2024年至2031年的複合年成長率為15.4%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	966.8億美元
實際資料	2019-2023	預測期	2024年至2031年
預測 2024-2031 年複合年成長率：	15.40%	2031 年金額預測	2631.7億美元

圖：2024 年按地區分類的癌症單株抗體市場佔有率(%)

癌症單株抗體是人工產生的蛋白質，能夠辨識癌細胞並與其自身結合。這些抗體由製藥公司商業性開發，用於識別和擊敗人體內的癌細胞，而不傷害正常細胞。抗體與癌細胞表面的特定分子結合，幫助人體的免疫系統選擇性地辨識和攻擊癌細胞。由於癌症發病率的增加、新抗體藥物的研發進展以及更容易患癌症的老年人口的增加，全球癌症單株抗體市場近期出現了顯著的趨勢。

市場動態：

2022年5月，世界衛生組織預計，到2040年，癌症新增病例數預計將達到2,700萬，癌症死亡人數將達1,630萬。另一個市場驅動力是持續的研究和開發，導致發現新型單株抗體藥物和針對各種癌症類型的聯合治療，從而改善患者的治療結果。然而，單株抗體藥物的高成本是其廣泛使用的主要阻礙因素。嚴格的法規和漫長的產品核可時間加劇了挑戰。市場抓住了醫療保健支出不斷增加的新興國家帶來的利潤豐厚的機會。

本研究的主要特點

該報告對全球癌症單株抗體市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。

它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

根據公司亮點、產品系列、主要亮點、績效和策略等參數對全球癌症單株抗體市場的主要企業進行了分析。

本研究涵蓋的主要企業包括 Abnova Corporation、BioGenex、Bio-Rad Laboratories, Inc.、AMSBIO、Elabscience Bionovation Inc.、Fortis Life Sciences、Creative Diagnostics、Rockland Immunochemicals, Inc.、GenScript、Leinco Technologies、Abcam Limited、Sino Biological 、公司等

該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。

全球癌症單株抗體市場報告針對該行業的各個相關人員相關者，如投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。

透過用於分析全球癌症單株抗體市場的各種策略矩陣，將有助於相關人員做出決策。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	96.68 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	15.40%	2031 Value Projection:	263.17 Bn

Cancer monoclonal antibodies are artificially created proteins that have the capability to identify and bind themselves to cancer cells. These antibodies are commercially developed by pharmaceutical companies to identify and overcome cancer cells in the human body without harming normal cells. They work by attaching themselves to specific molecules found on cancer cell surfaces and helping the body's own immune system to recognize and attack those cancer cells selectively. The global cancer monoclonal antibodies market has witnessed tremendous growth in recent years due to the increasing prevalence of cancer, ongoing research, and development leading to novel antibody drugs and the growing geriatric population which is more prone to cancer.

Market Dynamics:

The global cancer monoclonal antibodies market growth is driven by the rising incidence of cancer worldwide owing to factors like increasing tobacco consumption, exposure to carcinogenic substances, changing lifestyle patterns, and growing elderly population. in May 2022, as per the WHO estimates, cancer burden is expected to reach 27 million new cases and 16.3 million cancer deaths by 2040. Another major market growth driver is the ongoing research and development leading to the discovery of novel monoclonal antibody drugs and combination therapies for various cancer types which has improved patient outcomes. However, high costs associated with monoclonal antibody drugs acts as a major restraint for widespread adoption. Also, stringent regulatory policies and lengthy product approval process adds to the challenges. The market sees lucrative opportunities arising from emerging economies with growing healthcare expenditures.

Key Features of the Study:

This report provides in-depth analysis of the global cancer monoclonal antibodies market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global cancer monoclonal antibodies market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abnova Corporation, BioGenex, Bio-Rad Laboratories, Inc., AMSBIO, Elabscience Bionovation Inc., Fortis Life Sciences, Creative Diagnostics, Rockland Immunochemicals, Inc., GenScript, Leinco Technologies, Abcam Limited, and Sino Biological, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global cancer monoclonal antibodies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer monoclonal antibodies market

Market Segmentation

By Source Insights (Revenue, USD Bn, 2019 - 2031)
- Human
- Chimeric
- Murine
- Humanized
By Application Insights (Revenue, USD Bn, 2019 - 2031)
- Blood Cancer
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Liver Cancer
- Others
By End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospital
- Clinical and Diagnostic Laboratories
- Research Institutes
- Others
Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Abnova Corporation
- BioGenex
- Bio-Rad Laboratories, Inc.
- AMSBIO
- Elabscience Bionovation Inc.
- Fortis Life Sciences
- Creative Diagnostics
- Rockland Immunochemicals, Inc.
- GenScript
- Leinco Technologies
- Abcam Limited
- Sino Biological, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Cancer Monoclonal Antibodies Market, By Source
- Cancer Monoclonal Antibodies Market, By Application
- Cancer Monoclonal Antibodies Market, By End User
- Cancer Monoclonal Antibodies Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Market Trends
Key Developments

4. Cancer Monoclonal Antibodies Market, By Source, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Human
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Chimeric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Murine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Humanized
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Cancer Monoclonal Antibodies Market, By Application, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Blood Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Liver Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Cancer Monoclonal Antibodies Market, By End User, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Clinical and Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Cancer Monoclonal Antibodies Market, By Region, 2019 - 2031, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Abnova Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BioGenex
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AMSBIO
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Elabscience Bionovation Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fortis Life Sciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Creative Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Rockland Immunochemicals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GenScript
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Leinco Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abcam Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sino Biological, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies